Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,717
Closed -$338K 810
2024
Q3
$338K Buy
+9,717
New +$332K ﹤0.01% 625
2023
Q3
Sell
-5,342
Closed -$244K 747
2023
Q2
$244K Hold
5,342
﹤0.01% 662
2023
Q1
$239K Hold
5,342
﹤0.01% 676
2022
Q4
$235K Sell
5,342
-993
-16% -$44.7K ﹤0.01% 663
2022
Q3
$266K Buy
6,335
+61
+1% +$2.96K ﹤0.01% 577
2022
Q2
$309K Buy
6,274
+442
+8% +$23.7K ﹤0.01% 541
2022
Q1
$323K Hold
5,832
﹤0.01% 568
2021
Q4
$303K Sell
5,832
-16,127
-73% -$824K ﹤0.01% 595
2021
Q3
$1.1M Buy
21,959
+233
+1% +$11.8K 0.01% 214
2021
Q2
$1.07M Buy
21,726
+15,154
+231% +$734K 0.01% 219
2021
Q1
$297K Buy
6,572
+1,397
+27% +$61.6K ﹤0.01% 551
2020
Q4
$221K Sell
5,175
-44
-0.8% -$1.88K ﹤0.01% 569
2020
Q3
$216K Buy
+5,219
New +$221K ﹤0.01% 501
2018
Q2
Sell
-4,741
Closed -$204K 519
2018
Q1
$204K Hold
4,741
﹤0.01% 426
2017
Q4
$228K Hold
4,741
﹤0.01% 408
2017
Q3
$222K Buy
+4,741
New +$222K ﹤0.01% 377

Other funds holding BCE

Greenleaf Trust's BCE Position: Q4 2024 in Review

Greenleaf Trust sold out of BCE (BCE) in Q4 2024, closing a stake of 9,717 shares — an estimated $338K sold.

Greenleaf Trust first reported a position in BCE in Q3 2017 and held it in 16 quarters. The position peaked at $1.1M in Q3 2021. 430 funds tracked by Wall St. Rank hold BCE as of Q4 2024.

  • Greenleaf Trust reported no remaining BCE position as of Q4 2024 after selling out during the quarter.
  • Greenleaf Trust sold 9,717 BCE shares in Q4 2024, an estimated $338K.
  • Greenleaf Trust first reported a position in BCE in Q3 2017 and held it in 16 quarters.
  • Greenleaf Trust's BCE position peaked at $1.1M in Q3 2021.
  • 430 funds tracked by Wall St. Rank held BCE as of Q4 2024.

Based on Greenleaf Trust's 13F filing for Q4 2024, filed 24 Jan 2025.